fda declaratory order semaglutide shortage resolved feb 21 2025 Announces Resolution of Injection Product Shortag US FDA Employs Familiar Strategy

Specialty drugs including biologics, injectables, and GLP-1 medications almost always require PA because of their high cost and complex medical necessity criteria

doi: 10.1016/S0022-3999(02)00429-4 [DOI] [PubMed] [Google Scholar] 193

SNIP1 mutations in the FHA domain affect cell viability and pre-mRNA splicing To determine whether mutations in the SNIP1 FHA domain affect incorporation of SNIP1 into the activated spliceosome, we expressed flag-tagged SNIP1 (F-SNIP1) WT, single mutants K265G, K301G, R365G, E366G, and the double mutant K265G/K301G in cells and compared their association with components of the activated spliceosome (Fig

(A and B) Western blot analysis of ASYM and SYM levels in NCI-H446 cells at indicated time points after chemotherapy

2f), suggesting a requirement for MTs in the development and juxtanuclear localization of the C